Literature DB >> 24926778

Functional gene variants of CYP3A4.

A N Werk1, I Cascorbi1.   

Abstract

Cytochrome P450 3A4 (CYP3A4) is involved in the metabolism of more drugs in clinical use than any other foreign compound-metabolizing enzyme in humans. Recently, increasing evidence has been found showing that variants in the CYP3A4 gene have functional significance and--in rare cases--lead to loss of activity, implying tremendous consequences for patients. This review article highlights the functional consequences of all CYP3A4 variants recognized by the Human Cytochrome P450 (CYP) Allele Nomenclature Database.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24926778     DOI: 10.1038/clpt.2014.129

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  47 in total

Review 1.  Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.

Authors:  Narumi Uno; Satoshi Abe; Mitsuo Oshimura; Yasuhiro Kazuki
Journal:  J Hum Genet       Date:  2017-11-27       Impact factor: 3.172

2.  Quantitative Prediction of CYP3A4- and CYP3A5-Mediated Drug Interactions.

Authors:  Yingying Guo; Aroonrut Lucksiri; Gemma L Dickinson; Raj K Vuppalanchi; Janna K Hilligoss; Stephen D Hall
Journal:  Clin Pharmacol Ther       Date:  2019-09-12       Impact factor: 6.875

3.  CYP3A4 intronic SNP rs35599367 (CYP3A4*22) alters RNA splicing.

Authors:  Danxin Wang; Wolfgang Sadee
Journal:  Pharmacogenet Genomics       Date:  2016-01       Impact factor: 2.089

4.  Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.

Authors:  Kyoung-Ah Kim; In-Bae Park; Ji-Young Park
Journal:  Eur J Clin Pharmacol       Date:  2018-06-13       Impact factor: 2.953

5.  Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism.

Authors:  Sara K Quinney; Tara Benjamin; Xiaomei Zheng; Avinash S Patil
Journal:  Fetal Pediatr Pathol       Date:  2017-09-26       Impact factor: 0.958

6.  Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.

Authors:  Ivan Skadrić; Oliver Stojković
Journal:  Int J Legal Med       Date:  2019-12-20       Impact factor: 2.686

7.  Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.

Authors:  Shinya Maekawa; Mitsuaki Sato; Natsuhiko Kuratomi; Taisuke Inoue; Yuichiro Suzuki; Akihisa Tatsumi; Mika Miura; Shuya Matsuda; Masaru Muraoka; Natsuko Nakakuki; Fumitake Amemiya; Shinichi Takano; Mitsuharu Fukasawa; Yasuhiro Nakayama; Tatsuya Yamaguchi; Tadashi Sato; Minoru Sakamoto; Miyako Murakawa; Mina Nakagawa; Yasuhiro Asahina; Nobuyuki Enomoto
Journal:  J Gastroenterol       Date:  2017-11-01       Impact factor: 7.527

8.  Ligand-Free Estrogen Receptor α (ESR1) as Master Regulator for the Expression of CYP3A4 and Other Cytochrome P450 Enzymes in the Human Liver.

Authors:  Danxin Wang; Rong Lu; Grzegorz Rempala; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2019-08-09       Impact factor: 4.436

Review 9.  The Pharmacogenetics of Tramadol.

Authors:  Dorte Lassen; Per Damkier; Kim Brøsen
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447

10.  Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.

Authors:  Noël Knops; Jean Herman; Maria van Dyck; Yasaman Ramazani; Edward Debbaut; Rita van Damme-Lombaerts; Elena Levtchenko; Lambertus P van den Heuvel; Steffen Fieuws; Dirk Kuypers
Journal:  Br J Clin Pharmacol       Date:  2016-12-13       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.